Individual, Neighborhood-Level Social Risk Indicators Provide Distinct Health Care Use Insights
EHR-Based Symptom Inventory Shows Potential for Ovarian Cancer Monitoring
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
Zanubrutinib May Lead to Cost Savings vs Ibrutinib in R/R CLL
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.